Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database
Purpose: To analyze the risk of enfortumab vedotin (EV), a targeted therapy for advanced bladder cancer, using real-world data from the U.S. Food and Drug Administration's Federal Adverse Event Reporting System (FAERS). Methods: A retrospective pharmacovigilance analysis was conducted using FAERS da...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2024-09-01
|
| Schriftenreihe: | Heliyon |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S240584402413575X |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
